MedTrace Logo

Early Detection of Cognitive Decline

NCT05804981 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2025-12-03

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the impact of a brief cognitive screener on provider behavior in patients completing an annual wellness visit (AWV). The main question\[s\] it aims to answer are:

* do appropriate referrals increase for patients using the new screener?
* do appropriate diagnostic orders increase for patients using the new screener? Participants will respond to 4 questions about their cognitive abilities as part of a larger AWV protocol.

Researchers will compare provider behavior for patients completing AWVs before and after implementation of the new screener to see if referral, diagnostic and prescribing behaviors differ.

Conditions

Interventions

OTHER

PRO-CS

4 questions about cognitive function added to annual wellness visit protocol

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • University of Pittsburgh Medical Center

    collaborator OTHER

  • Northwestern University

    collaborator OTHER

  • RAND

    lead OTHER

Principal Investigators

  • Maria Edelen, PhD · RAND

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2024-01-19
Completion
2024-01-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05804981 on ClinicalTrials.gov